- Research works
- 5 ▼ 32% vs 2013–17
- Citations
- 55 12.0 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 46% world 28%
Not ranked overall: Centrient Pharmaceuticals (Netherlands) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does Centrient Pharmaceuticals (Netherlands) publish most on?
By volume in 2022–2025: Laser Applications in Dentistry and Medicine, Diabetic Foot Ulcer Assessment and Management and Wound Healing and Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Laser Applications in Dentistry and Medicine Radiology, Nuclear Medicine and Imaging 0 works
- 2 Diabetic Foot Ulcer Assessment and Management Endocrinology, Diabetes and Metabolism 0 works
- 3 Wound Healing and Treatments Rehabilitation 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Centrient Pharmaceuticals (Netherlands)'s research output changed?
Output in 2018–2022 was 32% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Rotterdam
- Erasmus University Rotterdam
- Erasmus MC
- Rotterdam University of Applied Sciences
- Erasmus MC - Sophia Children’s Hospital
- Chevron (Netherlands)
- Erasmus MC Cancer Institute
- Tinbergen Institute
- Unilever (Netherlands)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.